Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Rose

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
International Immunopharmacology|May 30, 2020
Antileishmanial drugs activate inflammatory signaling pathways via toll-like receptors (docking approach) from Leishmania amazonensis-infected macrophagesJoão Rafael Valentim-Silva, Sharon Rose Aragão Macedo, Neuza Biguinati de Barros, et al.
Physiological Genomics|July 8, 2024
Deciphering taxonomic and functional patterns of microbial communities associated with the tiger tail seahorse (<i>Hippocampus comes</i>)Chinee Surita Padasas-Adalla, Rose Chinly Mae Ortega-Kindica, Rodelyn Dalayap, et al.
Marine Biotechnology (New York, N.Y.)|June 12, 2024
Shotgun Metagenomics Reveals Taxonomic and Functional Patterns of the Microbiome Associated with Barbour's Seahorse (Hippocampus barbouri)Rose Chinly Mae H Ortega-Kindica, Chinee S Padasas-Adalla, Sharon Rose M Tabugo, et al.
Scientific Reports|April 23, 2021
Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non respondersMegan H Trager, Emanuelle Rizk, Sharon Rose, et al.
World Journal of Orthopedics|January 2, 2026
Comparative study between combined oblique and vertical everting running stitch and the conventional suturing techniqueMohammed Sadiq, Sharon Rose Neerudi, Rohith Reddy Kasam, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|November 5, 2016
Screening of the in vitro antileishmanial activities of compounds and secondary metabolites isolated from Maytenus guianensis Klotzsch ex Reissek (Celastraceae) chichuá AmazonDionatas Ulises de Oliveira Meneguetti, Renato Abreu Lima, Fernanda Bay Hurtado, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 14, 2022
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODAMarc H Hemmelder, Marlies Noordzij, Priya Vart, et al.
Experimental Parasitology|July 23, 2020
A natural cell-penetrating nanopeptide combined with pentavalent antimonial as experimental therapy against cutaneous leishmaniasisJoão Rafael Valentim Silva, Neuza Biguinati de Barros, Sharon Rose Aragão Macedo, et al.
Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2018
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumabPatrick M Brunner, Ana B Pavel, Saakshi Khattri, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
International Immunopharmacology|May 30, 2020
Antileishmanial drugs activate inflammatory signaling pathways via toll-like receptors (docking approach) from Leishmania amazonensis-infected macrophagesJoão Rafael Valentim-Silva, Sharon Rose Aragão Macedo, Neuza Biguinati de Barros, et al.
Physiological Genomics|July 8, 2024
Deciphering taxonomic and functional patterns of microbial communities associated with the tiger tail seahorse (<i>Hippocampus comes</i>)Chinee Surita Padasas-Adalla, Rose Chinly Mae Ortega-Kindica, Rodelyn Dalayap, et al.
Marine Biotechnology (New York, N.Y.)|June 12, 2024
Shotgun Metagenomics Reveals Taxonomic and Functional Patterns of the Microbiome Associated with Barbour's Seahorse (Hippocampus barbouri)Rose Chinly Mae H Ortega-Kindica, Chinee S Padasas-Adalla, Sharon Rose M Tabugo, et al.
Scientific Reports|April 23, 2021
Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non respondersMegan H Trager, Emanuelle Rizk, Sharon Rose, et al.
World Journal of Orthopedics|January 2, 2026
Comparative study between combined oblique and vertical everting running stitch and the conventional suturing techniqueMohammed Sadiq, Sharon Rose Neerudi, Rohith Reddy Kasam, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|November 5, 2016
Screening of the in vitro antileishmanial activities of compounds and secondary metabolites isolated from Maytenus guianensis Klotzsch ex Reissek (Celastraceae) chichuá AmazonDionatas Ulises de Oliveira Meneguetti, Renato Abreu Lima, Fernanda Bay Hurtado, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 14, 2022
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODAMarc H Hemmelder, Marlies Noordzij, Priya Vart, et al.
Experimental Parasitology|July 23, 2020
A natural cell-penetrating nanopeptide combined with pentavalent antimonial as experimental therapy against cutaneous leishmaniasisJoão Rafael Valentim Silva, Neuza Biguinati de Barros, Sharon Rose Aragão Macedo, et al.
Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2018
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumabPatrick M Brunner, Ana B Pavel, Saakshi Khattri, et al.
Pageof 7